Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Biotech Podcast: 数据出境新规解读,EHA和ADA的中国数据发布

Executive Summary

In this Chinese-language podcast episode, "Angus" Shipo Xie, a lawyer at Han Kun Law, joins Brian Yang to discuss the implications of China's updated Data Overseas Transfer rules issued in late March. Dexter Yan explains clinical data released by Hutchmed, Jiangsu Hengrui and Innovent Bio at the recent EHA and ADA annual conferences.


恒瑞医药和信达生物分别在ADA年会上发布了减肥药GLP-1受体/GIP 受体双重激动剂,和减肥药GLP-1受体/GCG受体双重激动剂的临床试验结果。在诺和诺德获得GLP-1治疗肥胖在中国批准之后,这两家中国生物药企如何差异化竞争?



Special guest, "Angus" Shipo Xie from Han Kun Law, joins Brian Yang and Dexter Yan to discuss recent trending topics in the China biotech sector. Dexter also talks about the recent clinical data readouts presented at the recent European Hematology Association and American Diabetes Association meetings by Chinese firms HUTCHMED (China) Limited on sovleplenib, Jiangsu Hengrui Medicine Co., Ltd. on its GLP-1/GIP receptor agonist and Innovent Biologics, Inc. on a GLP-1/GCG receptor agonist. 

In the second part of the podcast, Angus explains notable changes to China's new rules on Promoting and Regulating Overseas Data Transfers, issued on 22 March by the national Cybersecurity Administration. What do the new changes mean for drug makers, what are the notable points worth paying close attention and what should companies do to be compliant?

Stories mentioned in this episode:

(Also see "China Phase III Results Boost Global Prospects For HUTCHMED ITP Drug" - Scrip, 18 Jun, 2024.)

(Also see "China Implements Data Transfer Regulation, With Some Waivers" - Pink Sheet, 3 Apr, 2024.)

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts